Help! Please Register

  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Astellas Pharma Inc.

conference highlightsConference Highlights

Focus on Fungal Infections 12


Clinical Mycology
  1. CLINICAL PREDICTIVE MODEL FOR NEONATAL CANDIDEMIA
    Benjamin, Jr., D.K.,
    United States
    March 2002


  2. COMBINATION AND SEQUENTIAL ANTIFUNGAL THERAPY FOR INVASIVE ASPERGILLOSIS: REVIEW OF ALL IN VITRO, IN VIVO, AND CLINICAL ANTIFUNGAL TREATMENT
    Steinbach, W.J.,
    United States
    March 2002


  3. COMPARISON OF RESPONSE RATES TO CASPOFUNGIN IN PATIENTS WITH ESOPHAGEAL CANDIDIASIS DUE TO CANDIDA ALBICANS WITH AND WITHOUT NON-ALBICANS CANDIDA ISOLATES
    DiNubile, M.J.; Lupinacci, R.J., and Sable, C.A.,
    United States
    March 2002


  4. CYTOLOGICAL INVESTIGATION ON TRICHOSPORON SP. IN THE URINE CYTOLOGICAL SPECIMEN
    Muraishi, Y.; Taguchi, K.; Fujita, M.; Iwahara, M.; Oharaseki, T.; Takahashi, K.; Shibuya, K., and Naoe, S.,
    Japan
    March 2002


  5. DOES ANTIBIOTIC RESTRICTION REDUCE THE INCIDENCE OF CANDIDEMIA?
    Liu, E.; Whittier, S., and Frank, E.,
    United States
    March 2002


  6. EFFECTIVENESS OF USING DIFLUKAN IN PRETERM INFANTS BORN TO MOTHERS WITH CYTOMEGALOVIRUS INFECTION
    Sharapov, B.U.; Mavlyanova, S.Z., and Daminov, T.A.,
    Uzbekastan
    March 2002


  7. EPIDEMIOLOGY OF CANDIDA BLOODSTREAM INFECTIONS IN THE INTENSIVE CARE UNIT
    Gundarson, S.M.; Ristow, K.L.; Schreckenberger, P.C., and Danziger, L.H.,
    United States
    March 2002


  8. HISTOPATHOLOGICAL ANALYSIS OF RENAL CANDIDIASIS
    Wakayama, M.; Shibuya, K.; Ando, T.; Oharaseki, T., and Takahashi, K.,
    Japan
    March 2002


  9. INFLUENCE OF FLUCONAZOLE USE ON THE PREVALENCE OF CANDIDA ISOLATES FROM HOSPITALIZED PATIENTS
    Gundarson, S.M.; Ristow, K.L.; Schreckenberger, P.C., and Danziger, L.H.,
    United States
    March 2002


  10. INVASIVE FILAMENTOUS FUNGAL INFECTIONS IN HEMATOPOIETIC TRANSPLANT RECIPIENTS AFTER RECOVERY FROM NEUTROPENIA
    Segal, B.H.; Shaukat, A.; Bakril, F.; Young, P.; McCarthy, Jr., P.L.; Loud, P.; Cheney, R.T., and Walsh, T.J.,
    United States
    March 2002


  11. INVASIVE PULMONARY FILAMENTOUS FUNGAL INFECTION IN A PATIENT RECEIVING INHALED CORTICOSTEROID THERAPY
    Segal, B.H.; Peter, E.; Bakri, F.; Ball, D., and Cheney, R.T.,
    United States
    March 2002


  12. RESULTS IN PATIENTS WITH ESOPHAGEAL (EC), OROPHARYNGEAL (OPC), OR INVASIVE (IC) CANDIDIASIS FROM THE CASPOFUNGIN (CAS) COMPASSIONATE USE (CU) STUDY
    Kartsonis, N.; Saah, A.J.; Lipka, C.J.; Pohl, E.R., and Sable, C.A.,
    United States
    March 2002


  13. VORICONAZOLE FOR THE TREATMENT OF COCCIDIOIDES IMMITIS MENINGITIS: REPORT OF A CASE
    Proia, L.A., and Tenorio, A.R.,
    United States
    March 2002


top of page    




View other categories
Antifungal Agents | Antifungal Combinations | Basic Mycology
Case Reports | Clinical Mycology | Diagnostics | View All





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif